A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
The drug targeted inflammation, and its shocking failure has experts [...]
The drug targeted inflammation, and its shocking failure has experts [...]
The partnership marks Basuch + Lomb’s foray into the digital [...]
In a remarkable turnaround, Replimune has reversed the fortune of [...]
Takeda’s first-in-class orexin treatment won an FDA nod for narcolepsy. [...]
Plus, what happens when you have an A.I. boss.
Galderma Laboratories has landed a blow on Sanofi in its [...]
The agency had initially refused to even review the application [...]
Weber Shandwick and Reddit partnered up in a July report [...]
The PCSK9 cholesterol drug class has long been viewed as [...]
Years of litigation surrounding Gilead Sciences’ tenofivor-based HIV treatments have [...]